... annual surveillance. Conclusion: This case highlights the potential efficacy of combining tyrosine kinase inhibitor therapy with SBRT in managing aggressively progressive HLRCC. [email protected] 10 02 2025 22 06 2025 12 07 2025 © 2025 The Author(s). Published...

... functional insights into the clinical synergism with tyrosine kinase inhibitors. Preclinical and epidemiological studies in several malignancies suggest a tumor-suppressive role of metformin (MF), a biguanide originally used for treating type 2 diabetes [ 1 ]. There is increasing evidence that combining...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Vascular endothelial growth factor receptor Targeted therapy Tyrosine kinase inhibitor...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Tyrosine kinase inhibitor Metastatic renal cell carcinoma Toxic dermatolysis Amputation Urologia Internationalis...

... Molecular Therapy in Urologic Oncology Key Words Molecular therapy Targeted therapy Tyrosine kinase inhibitor Oncology Prostate cancer Bladder cancer Germ cell tumour Renal cell carcinoma Abstract During recent years, significant advances have been made in the field of molecular therapy...